Belvedere Trading LLC Biovie Inc. Transaction History

Belvedere Trading LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$2.75 - $5.17 $2,794 - $5,252	-1,016 Reduced 10.31%	8,842 $30,000
Q2 2023 Aug 08, 2023	BUY	$4.09 - $8.29 $28,838 - $58,452	7,051 Added 251.19%	9,858 $42,000
Q1 2023 May 15, 2023	BUY	$4.89 - $10.53 $13,726 - $29,557	2,807 New	2,807 $22,000

4.79M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $35.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.